글로벌 연구동향
방사선종양학
- 2020년 09월호
[Sci Rep.] Immune expression signatures as candidate prognostic biomarkers of age and gender survival differences in cutaneous melanoma이화의대 / 김이준, 김규보*
- 출처
- Sci Rep.
- 등재일
- 2020 Jul 23
- 저널이슈번호
- 10(1):12322. doi: 10.1038/s41598-020-69082-z.
- 내용
Abstract
This study aims to investigate the difference of gene expression and its prognostic significance in younger women with melanoma. Significantly upregulated genes in tumors compared to normal skin tissues were extracted. Among these genes, genes that significantly affected survival according to expression level were selected, and pathway annotation was performed. The patient proportion with high/low expression of the most significant pathways was analyzed in each age (< 50, 50-59, ≥ 60) and gender group. Survival was analyzed according to age, gender, and pathways. The most significant pathways that were upregulated in tumor tissues and also had impacts on survival were programmed cell death protein [PD]-1, interferon-γ, and interferon-α/β pathways. In women, the immune signaling rate in patients was higher than men and decreased with age (63.5%, 53.8%, and 47.6%). In men, the decreasing tendency was minimal (47.6%, 50.0%, and 41.6%). In patients aged < 60 years, women had a favorable survival rate than men (p = 0.055). Except for patients with high immune signaling, no survival difference was observed between genders (p = 0.6). In conclusion, younger female melanoma patients had high immune signaling than older women and men. This immune signaling improved survival of the younger female patients.Affiliations
Yi-Jun Kim 1 2 , Kyubo Kim 3 , Kye Hwa Lee 4 , Jiyoung Kim 1 , Wonguen Jung 1
1 Department of Radiation Oncology, Ewha Womans University College of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.
2 Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, 07985, Republic of Korea.
3 Department of Radiation Oncology, Ewha Womans University College of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea. kyubokim.ro@gmail.com.
4 Biomedical Informatics Department, Asan Medical Center, Seoul, 05505, Republic of Korea.
- 덧글달기
- 이전글 [Cancers (Basel).] Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer
- 다음글 [Int J Radiat Oncol Biol Phys.] Gut Microbiome Composition Is Associated with a Pathologic Response After Preoperative Chemoradiation in Patients with Rectal Cancer.